[Treatment and prevention of experimental pneumonias, caused by L forms of bacteria].
On a model of experimental pneumonia in mice caused by the L-forms of bacteria against the background of diminished immunity a study was made of the therapeutic efficacy of penicillin, lincomycin, lysozyme and gamma-globulin. Lincomycin, particularly in combination with biologically-active preparations, proved to be expedience for the treatment and prophylaxis of pneumonia caused by the mentioned bacteria; a rapid arrest of pneumonic process occurred and more animals survived. In the greater percentage of cases the use of penicillin was accompanied by generalization of the process.
D000818:Animals; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents; D007740:L Forms / Q000302:isolation & purification; D007945:Leukemia, Lymphoid / Q000382:microbiology; D008034:Lincomycin / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000494:pharmacology; D051379:Mice; D009113:Muramidase / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy*; D005719:gamma-Globulins / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D010406:Penicillins; D005719:gamma-Globulins; D008034:Lincomycin; D015122:Mercaptopurine; D009113:Muramidase
Lechenie i profilaktika éksperimental'nykh pnevmoniĭ, vyzvannykh L-formami bakterii